GlobeNewswire - News from Massachusetts http://www.yebxqs.cn/RssFeed/stateprovince/Massachusetts/feedTitle/GlobeNewswire%20-%20News%20from%20Massachusetts Contains the last 20 releases newsdesk@globenewswire.com (NewsDesk) Tue, 02 Mar 2021 14:00:00 GMT webmaster@globenewswire.com (Webmaster) http://www.yebxqs.cn/news-release/2021/03/02/2185378/0/en/CoinMover-to-Raise-Capital-for-the-Expansion-of-Bitcoin-ATM-Kiosks.html http://www.yebxqs.cn/news-release/2021/03/02/2185378/0/en/CoinMover-to-Raise-Capital-for-the-Expansion-of-Bitcoin-ATM-Kiosks.html CoinMover to Raise Capital for the Expansion of Bitcoin ATM Kiosks LYNN, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- CoinMover, a U.S.-based Bitcoin ATM kiosk company, for the first time, is working to secure outside funds to accelerate the expansion of its kiosk locations.

]]>
Tue, 02 Mar 2021 14:00 GMT 2185378 en GlobeNewswire Inc. CoinMover Tue, 02 Mar 2021 14:00 GMT Company Announcement Cryptocurrency Bitcoin Cryptocurrency Investment
http://www.yebxqs.cn/news-release/2021/03/02/2185382/0/en/Planned-and-Unplanned-Mid-Study-Updates-Pose-Major-Challenge-to-Clinical-Trial-Timelines-According-to-Tufts-Center-for-the-Study-of-Drug-Development.html http://www.yebxqs.cn/news-release/2021/03/02/2185382/0/en/Planned-and-Unplanned-Mid-Study-Updates-Pose-Major-Challenge-to-Clinical-Trial-Timelines-According-to-Tufts-Center-for-the-Study-of-Drug-Development.html Planned and Unplanned Mid-Study Updates Pose Major Challenge to Clinical Trial Timelines, According to Tufts Center for the Study of Drug Development Tufts Center for the Study of Drug Development Analysis Finds Larger Pharmaceutical Companies Experience Longer Delays due to Mid-Study Updates

]]>
Tue, 02 Mar 2021 14:00 GMT 2185382 en GlobeNewswire Inc. Tufts Center for the Study of Drug Development Tue, 02 Mar 2021 14:00 GMT Research Analysis and Reports Health Drug development Drug R&D US Food & Drug Administration presc FDA clinical development Clinical trial
http://www.yebxqs.cn/news-release/2021/03/02/2185337/0/en/Agenus-to-Provide-Corporate-Update-and-Fourth-Quarter-Full-Year-2020-Financial-Report.html http://www.yebxqs.cn/news-release/2021/03/02/2185337/0/en/Agenus-to-Provide-Corporate-Update-and-Fourth-Quarter-Full-Year-2020-Financial-Report.html Nasdaq:AGEN US00847G7051 Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report Conference Call on Monday, March 15, 2021 at 8:30 a.m. ET]]> Tue, 02 Mar 2021 13:30 GMT 2185337 en GlobeNewswire Inc. Agenus Inc. Tue, 02 Mar 2021 13:31 GMT Calendar of Events http://www.yebxqs.cn/news-release/2021/03/02/2185343/0/en/Vericel-Announces-Webcast-of-Presentation-at-Upcoming-H-C-Wainwright-Virtual-Global-Life-Sciences-Conference.html http://www.yebxqs.cn/news-release/2021/03/02/2185343/0/en/Vericel-Announces-Webcast-of-Presentation-at-Upcoming-H-C-Wainwright-Virtual-Global-Life-Sciences-Conference.html Nasdaq:VCEL US92346J1088 Vericel Announces Webcast of Presentation at Upcoming H.C. Wainwright Virtual Global Life Sciences Conference CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Joe Mara, Chief Financial Officer, will present the latest company overview at the H.C. Wainwright Virtual Global Life Sciences Conference. The conference is being conducted in a virtual format and a webcast of the presentation will become available on Tuesday, March 9, 2021, at 7:00 a.m. Eastern Time.

]]>
Tue, 02 Mar 2021 13:30 GMT 2185343 en GlobeNewswire Inc. Vericel Corporation Tue, 02 Mar 2021 13:32 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/03/02/2185195/0/en/NetNumber-to-Acquire-SiRRAN-Communications-Ltd-and-TD-Mobile-AG.html http://www.yebxqs.cn/news-release/2021/03/02/2185195/0/en/NetNumber-to-Acquire-SiRRAN-Communications-Ltd-and-TD-Mobile-AG.html NetNumber to Acquire SiRRAN Communications Ltd and TD-Mobile AG Acquisitions Expand Portfolio Offerings for Mobile Network Operators, Reflects NetNumber’s Market Strength]]> Tue, 02 Mar 2021 13:00 GMT 2185195 en GlobeNewswire Inc. NetNumber Tue, 02 Mar 2021 13:00 GMT Company Announcement http://www.yebxqs.cn/news-release/2021/03/02/2185240/0/en/eGenesis-Announces-125-Million-Series-C-Financing.html http://www.yebxqs.cn/news-release/2021/03/02/2185240/0/en/eGenesis-Announces-125-Million-Series-C-Financing.html eGenesis Announces $125 Million Series C Financing Proceeds will advance two lead xenotransplantation programs in kidney failure and type 1 diabetes into first-in-human studies]]> Tue, 02 Mar 2021 13:00 GMT 2185240 en GlobeNewswire Inc. eGenesis Tue, 02 Mar 2021 13:02 GMT Company Announcement Financing Agreements http://www.yebxqs.cn/news-release/2021/03/02/2185246/0/en/Royal-Bank-of-Canada-Selects-FactSet-as-Market-Data-and-Technology-Provider-for-Wealth-Management-Teams.html http://www.yebxqs.cn/news-release/2021/03/02/2185246/0/en/Royal-Bank-of-Canada-Selects-FactSet-as-Market-Data-and-Technology-Provider-for-Wealth-Management-Teams.html NYSE:FDS Nasdaq:FDS US3030751057 Royal Bank of Canada Selects FactSet as Market Data and Technology Provider for Wealth Management Teams FactSet solutions to be deployed to over 8,000 RBC wealth management professionals across North America]]> Tue, 02 Mar 2021 13:00 GMT 2185246 en GlobeNewswire Inc. FactSet Research Systems Inc. Tue, 02 Mar 2021 13:02 GMT Business Contracts FACTSET RBC Royal Bank of Canada Wealth Management BANKING Canada Market data http://www.yebxqs.cn/news-release/2021/03/02/2185248/0/en/Armored-Things-Adds-Sports-Executive-Marshall-Glickman-to-Its-Board-of-Advisors.html http://www.yebxqs.cn/news-release/2021/03/02/2185248/0/en/Armored-Things-Adds-Sports-Executive-Marshall-Glickman-to-Its-Board-of-Advisors.html Armored Things Adds Sports Executive Marshall Glickman to Its Board of Advisors G2 Strategic CEO brings global sports management experience to crowd intelligence software company????

]]>
Tue, 02 Mar 2021 13:00 GMT 2185248 en GlobeNewswire Inc. Armored Things Tue, 02 Mar 2021 13:02 GMT Directors and Officers Julie Johnson Roberts Marshall Glickman Armored Things
http://www.yebxqs.cn/news-release/2021/03/02/2185263/0/en/MassMEDIC-s-IGNITE-Program-Closes-Record-Year-Announces-Winners.html http://www.yebxqs.cn/news-release/2021/03/02/2185263/0/en/MassMEDIC-s-IGNITE-Program-Closes-Record-Year-Announces-Winners.html MassMEDIC’s IGNITE Program Closes Record Year; Announces Winners Virtual Accelerator Graduates Secure $25+ Million in Funding]]> Tue, 02 Mar 2021 13:00 GMT 2185263 en GlobeNewswire Inc. MassMEDIC Tue, 02 Mar 2021 13:03 GMT Company Announcement medical devices medtech startups entrepreneurs funding accelerator Boston MassMEDIC http://www.yebxqs.cn/news-release/2021/03/02/2185270/0/en/Chiasma-to-Participate-in-the-H-C-Wainwright-Global-Life-Sciences-Conference.html http://www.yebxqs.cn/news-release/2021/03/02/2185270/0/en/Chiasma-to-Participate-in-the-H-C-Wainwright-Global-Life-Sciences-Conference.html Nasdaq:CHMA US16706W1027 Chiasma to Participate in the H.C. Wainwright Global Life Sciences Conference NEEDHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company, today announced that management will present a company overview at the H.C. Wainwright Global Life Sciences Conference, which is being held Tuesday, March 9th - Wednesday, March 10th, 2021.

]]>
Tue, 02 Mar 2021 13:00 GMT 2185270 en GlobeNewswire Inc. Chiasma Tue, 02 Mar 2021 13:04 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/03/02/2185271/0/en/Lotus-Cars-Selects-Industry-Leaders-Cerence-and-ECARX-to-Deliver-Voice-Powered-Innovations.html http://www.yebxqs.cn/news-release/2021/03/02/2185271/0/en/Lotus-Cars-Selects-Industry-Leaders-Cerence-and-ECARX-to-Deliver-Voice-Powered-Innovations.html Nasdaq:CRNC US1567271093 Lotus Cars Selects Industry Leaders Cerence and ECARX to Deliver Voice-Powered Innovations BURLINGTON, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced that it and ECARX will partner with Lotus Cars on voice-powered technologies. The initiative will bring simplified interaction and enhanced safety, productivity and enjoyment to Lotus Cars drivers worldwide.

]]>
Tue, 02 Mar 2021 13:00 GMT 2185271 en GlobeNewswire Inc. Cerence Inc. Tue, 02 Mar 2021 13:04 GMT Product / Services Announcement Cerence Lotus ECarX Voice Recognition
http://www.yebxqs.cn/news-release/2021/03/02/2185280/0/en/Keros-Therapeutics-to-Present-at-the-H-C-Wainwright-Global-Life-Sciences-2021-Virtual-Conference.html http://www.yebxqs.cn/news-release/2021/03/02/2185280/0/en/Keros-Therapeutics-to-Present-at-the-H-C-Wainwright-Global-Life-Sciences-2021-Virtual-Conference.html Nasdaq:KROS US4923271013 Keros Therapeutics to Present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference LEXINGTON, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that Keros President and Chief Executive Officer Jasbir S. Seehra, Ph.D. will present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference.

]]>
Tue, 02 Mar 2021 13:00 GMT 2185280 en GlobeNewswire Inc. Keros Therapeutics, Inc. Tue, 02 Mar 2021 13:04 GMT Company Announcement
http://www.yebxqs.cn/news-release/2021/03/02/2185182/0/en/Arch-Therapeutics-to-Present-at-the-H-C-Wainwright-Global-Life-Sciences-Conference-March-9-10-2021.html http://www.yebxqs.cn/news-release/2021/03/02/2185182/0/en/Arch-Therapeutics-to-Present-at-the-H-C-Wainwright-Global-Life-Sciences-Conference-March-9-10-2021.html Other OTC:ARTH US03939W1099 Arch Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021 Management to provide corporate update on Dermal Sciences and BioSurgery]]> Tue, 02 Mar 2021 12:50 GMT 2185182 en GlobeNewswire Inc. Arch Therapeutics, Inc. Tue, 02 Mar 2021 12:50 GMT Calendar of Events http://www.yebxqs.cn/news-release/2021/03/02/2185065/0/en/Evelo-Biosciences-to-Report-Fourth-Quarter-and-Full-Year-2020-Financial-Results-on-Tuesday-March-9-2021.html http://www.yebxqs.cn/news-release/2021/03/02/2185065/0/en/Evelo-Biosciences-to-Report-Fourth-Quarter-and-Full-Year-2020-Financial-Results-on-Tuesday-March-9-2021.html Nasdaq:EVLO US2997341035 Evelo Biosciences to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 9, 2021 CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Tuesday, March 9, 2021 to report its fourth quarter and full year 2020 financial results and discuss business highlights.

]]>
Tue, 02 Mar 2021 12:00 GMT 2185065 en GlobeNewswire Inc. Evelo Biosciences, Inc. Tue, 02 Mar 2021 12:00 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/03/02/2185083/0/en/Kymera-Therapeutics-Announces-First-in-Human-Dose-in-Phase-1-Trial-of-KT-474-a-First-in-Class-IRAK4-Protein-Degrader-to-Treat-Immune-Inflammatory-Diseases.html http://www.yebxqs.cn/news-release/2021/03/02/2185083/0/en/Kymera-Therapeutics-Announces-First-in-Human-Dose-in-Phase-1-Trial-of-KT-474-a-First-in-Class-IRAK4-Protein-Degrader-to-Treat-Immune-Inflammatory-Diseases.html Nasdaq:KYMR US5015751044 Kymera Therapeutics Announces First-in-Human Dose in Phase 1 Trial of KT-474, a First-in-Class IRAK4 Protein Degrader to Treat Immune-Inflammatory Diseases KT-474 is the first IRAK4 degrader, and first heterobifunctional small molecule protein degrader outside of oncology, to enter clinical development

]]>
Tue, 02 Mar 2021 12:00 GMT 2185083 en GlobeNewswire Inc. Kymera Therapeutics, Inc. Tue, 02 Mar 2021 12:01 GMT Health Product / Services Announcement
http://www.yebxqs.cn/news-release/2021/03/02/2185124/0/en/Aileron-Therapeutics-Announces-Enrollment-Expansion-for-Upcoming-Phase-1b-Clinical-Trial-of-ALRN-6924-in-Patients-with-Advanced-Non-Small-Cell-Lung-Cancer-NSCLC.html http://www.yebxqs.cn/news-release/2021/03/02/2185124/0/en/Aileron-Therapeutics-Announces-Enrollment-Expansion-for-Upcoming-Phase-1b-Clinical-Trial-of-ALRN-6924-in-Patients-with-Advanced-Non-Small-Cell-Lung-Cancer-NSCLC.html Nasdaq:ALRN US00887A1051 Aileron Therapeutics Announces Enrollment Expansion for Upcoming Phase 1b Clinical Trial?of ALRN-6924 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) -- Placebo-controlled trial anticipated to enroll 60 patients with advanced p53-mutated?NSCLC undergoing treatment with first-line carboplatin plus pemetrexed --

-- Trial anticipated to begin in second quarter 2021 with initial data anticipated at the end of 2021 and final results mid-2022 --

]]>
Tue, 02 Mar 2021 12:00 GMT 2185124 en GlobeNewswire Inc. Aileron Therapeutics, Inc. Tue, 02 Mar 2021 12:03 GMT Health Product / Services Announcement
http://www.yebxqs.cn/news-release/2021/03/02/2185020/0/en/Great-Elm-Healthcare-LLC-Subsidiary-Acquires-Advanced-Medical-DME-LLC-and-PM-Sleep-Lab-LLC.html http://www.yebxqs.cn/news-release/2021/03/02/2185020/0/en/Great-Elm-Healthcare-LLC-Subsidiary-Acquires-Advanced-Medical-DME-LLC-and-PM-Sleep-Lab-LLC.html Nasdaq:GEG US39036P2092 Great Elm Healthcare, LLC Subsidiary Acquires Advanced Medical DME, LLC and PM Sleep Lab, LLC Expands operating footprint in the Midwest with 9 additional locations in Kansas and Missouri

]]>
Tue, 02 Mar 2021 11:05 GMT 2185020 en GlobeNewswire Inc. Great Elm Group, Inc. Tue, 02 Mar 2021 11:05 GMT Mergers and Acquisitions
http://www.yebxqs.cn/news-release/2021/03/02/2184818/0/zh-hans/Anaqua-%E6%94%B6%E8%B4%AD-Quantify-IP-%E6%97%A8%E5%9C%A8%E6%8E%8C%E6%8F%A1%E5%85%88%E8%BF%9B%E7%9A%84%E7%9F%A5%E8%AF%86%E4%BA%A7%E6%9D%83%E6%88%90%E6%9C%AC%E9%A2%84%E7%AE%97%E5%8F%8A%E9%A2%84%E6%B5%8B%E8%83%BD%E5%8A%9B.html http://www.yebxqs.cn/news-release/2021/03/02/2184818/0/zh-hans/Anaqua-%E6%94%B6%E8%B4%AD-Quantify-IP-%E6%97%A8%E5%9C%A8%E6%8E%8C%E6%8F%A1%E5%85%88%E8%BF%9B%E7%9A%84%E7%9F%A5%E8%AF%86%E4%BA%A7%E6%9D%83%E6%88%90%E6%9C%AC%E9%A2%84%E7%AE%97%E5%8F%8A%E9%A2%84%E6%B5%8B%E8%83%BD%E5%8A%9B.html Anaqua 收购 Quantify IP 旨在掌握先进的知识产权成本预算及预测能力 本次收购将 Global IP Estimator 和 Portfolio Estimator 揽入麾下?令知识产权管理产品如虎添翼]]> Tue, 02 Mar 2021 01:00 GMT 2184818 zh-Hans GlobeNewswire Inc. Anaqua Inc Tue, 02 Mar 2021 01:00 GMT Business Contracts Company Announcement Mergers and Acquisitions Partnerships Product / Services Announcement http://www.yebxqs.cn/news-release/2021/03/02/2184818/0/ko/Anaqua-%EA%B3%A0%EA%B8%89-%EC%A7%80%EC%A0%81%EC%9E%AC%EC%82%B0-%EB%B9%84%EC%9A%A9-%EC%98%88%EC%82%B0-%EB%B0%8F-%EC%98%88%EC%B8%A1-%EA%B8%B0%EB%8A%A5-%EC%A0%9C%EA%B3%B5%EC%9D%84-%EC%9C%84%ED%95%B4-Quantify-IP-%EC%9D%B8%EC%88%98.html http://www.yebxqs.cn/news-release/2021/03/02/2184818/0/ko/Anaqua-%EA%B3%A0%EA%B8%89-%EC%A7%80%EC%A0%81%EC%9E%AC%EC%82%B0-%EB%B9%84%EC%9A%A9-%EC%98%88%EC%82%B0-%EB%B0%8F-%EC%98%88%EC%B8%A1-%EA%B8%B0%EB%8A%A5-%EC%A0%9C%EA%B3%B5%EC%9D%84-%EC%9C%84%ED%95%B4-Quantify-IP-%EC%9D%B8%EC%88%98.html Anaqua, ?? ???? ?? ?? ? ?? ?? ??? ?? Quantify IP ?? ??? ?? Global IP Estimator ? Portfolio Estimator? ????IP ?? ??? ?? ? ?? ???]]> Tue, 02 Mar 2021 01:00 GMT 2184818 ko GlobeNewswire Inc. Anaqua Inc Tue, 02 Mar 2021 01:00 GMT Business Contracts Company Announcement Mergers and Acquisitions Partnerships Product / Services Announcement http://www.yebxqs.cn/news-release/2021/03/02/2184818/0/zh-hant/Anaqua%E6%94%B6%E8%B3%BCQuantify-IP%E4%BB%A5%E6%8F%90%E4%BE%9B%E5%85%88%E9%80%B2%E7%9A%84%E6%99%BA%E6%85%A7%E8%B2%A1%E7%94%A2%E6%88%90%E6%9C%AC%E9%A0%90%E7%AE%97%E5%92%8C%E9%A0%90%E6%B8%AC%E8%83%BD%E5%8A%9B.html http://www.yebxqs.cn/news-release/2021/03/02/2184818/0/zh-hant/Anaqua%E6%94%B6%E8%B3%BCQuantify-IP%E4%BB%A5%E6%8F%90%E4%BE%9B%E5%85%88%E9%80%B2%E7%9A%84%E6%99%BA%E6%85%A7%E8%B2%A1%E7%94%A2%E6%88%90%E6%9C%AC%E9%A0%90%E7%AE%97%E5%92%8C%E9%A0%90%E6%B8%AC%E8%83%BD%E5%8A%9B.html Anaqua收購Quantify IP以提供先進的智慧財產成本預算和預測能力 收購透過Global IP Estimator和Portfolio Estimator?擴展和增強智慧財產管理產品]]> Tue, 02 Mar 2021 01:00 GMT 2184818 zh-Hant GlobeNewswire Inc. Anaqua Inc Tue, 02 Mar 2021 01:00 GMT Business Contracts Company Announcement Mergers and Acquisitions Partnerships Product / Services Announcement
粉色午夜视频/色戒未删减版在线观看视频/44383x3全国最大的免费观看/冲田杏梨番号